DavidSchiffMD
Neurology • Charlottesville, VANeurooncology
Harrison Distinguished Teaching Professor of Neurology, University of Virginia School of Medicine
Dr. Schiff is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Connect with other colleagues in the same hospital or clinic
- Search all U.S. specialist profiles and refer a patient
- Read the latest clinical news and earn CME/CEU credits
Office
1215 Hospital Dr
Charlottesville, VA 22908Phone+1 434-924-9449Fax+1 434-982-5793- Is this information wrong?
Education & Training
Brigham and Women's HospitalInternship, Internal Medicine, 1988 - 1989
Harvard Medical SchoolClass of 1988
Certifications & Licensure
AZ State Medical License 1996 - Present
VA State Medical License 2001 - 2024
PA State Medical License 1996 - 2002
MN State Medical License 1993 - 1997- American Board of Psychiatry and Neurology Neurology
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2013
- CMS Meaningful Use Stage 1 Certification EpicCare Inpatient - Core EMR, Epic Systems Corporation, 2012
Clinical Trials
- Imatinib Mesylate in Treating Patients With Recurrent Brain Tumor Start of enrollment: 2003 Jun 01
- Everolimus, Temozolomide, and Radiation Therapy in Treating Patients With Newly Diagnosed Glioblastoma Start of enrollment: 2009 Mar 01
- A Study of 131I-TM601 in Adults With Recurrent Malignant Glioma Start of enrollment: 2008 Aug 01
- Join now to see all
Publications & Presentations
PubMed
- Phase I study targeting newly diagnosed grade 4 astrocytoma with bispecific antibody armed T cells (EGFR BATs) in combination with radiation and temozolomide.Thakur, A., Kim, J., Kassay-McAllister, J., Schalk, D., Lopes, M., Liu, Q., Fadul, C., Donahue, J., Purow, B., Dillon, P., Le, T., Schiff, D., Lum, L.> ;Journal of Neuro-Oncology. 2024 Jan 1
- 3 citationsBrain tumor-related epilepsy management: A Society for Neuro-oncology (SNO) consensus review on current management.Edward K Avila, Steven Tobochnik, Sara K Inati, Johan A F Koekkoek, Guy M McKhann, James J Riviello, Roberta Rudà, David Schiff, William O Tatum, Jessica W Templer, Mi...> ;Neuro-Oncology. 2024 Jan 5
- 1 citationsHeadway against Brain Tumors with Molecular Targeting of IDH-Mutant Gliomas.David Schiff> ;The New England Journal of Medicine. 2023 Aug 17
- Join now to see all
Journal Articles
- Phase I Study of Pomalidomide and Dexamethasone for relapsed/refractory Primary CNS or Vitreo-Retinal LymphomaLisa M DeAngelis, Han W Tun, David Schiff, Kurt A Jaeckle, Christian Grommes, Patrick B Johnston, Craig B Reeder, Thomas E Witzig, Blood
Other
- Discovery and Therapeutic Exploitation of Mechanisms of Resistance to MET Inhibitors in GlioblastomaDavid Schiff, MD, Clinical Cancer Research
https://www.doximity.com/articles/e5ba8350-d6fc-4d24-833f-8632cfbcc6e1
UpToDate, Wolters Kluwer Health - 2012-07-30 - Discovery and Therapeutic Exploitation of Mechanisms of Resistance to MET Inhibitors in GlioblastomaDavid Schiff, MD, Clinical Cancer Research
https://www.doximity.com/articles/e5ba8350-d6fc-4d24-833f-8632cfbcc6e1
UpToDate, Wolters Kluwer Health - 2012-04-09 - Discovery and Therapeutic Exploitation of Mechanisms of Resistance to MET Inhibitors in GlioblastomaDavid Schiff, MD, Clinical Cancer Research
https://www.doximity.com/articles/e5ba8350-d6fc-4d24-833f-8632cfbcc6e1
UpToDate, Wolters Kluwer Health - 2012-08-28 - Join now to see all
Press Mentions
New Brain Cancer Guidelines to Improve Care, Patient SurvivalJanuary 26th, 2022
Professional Memberships
- Member
- Member
Hospital Affiliations
University of Virginia Medical CenterCharlottesville, Virginia- Emily Couric Clinical Cancer CenterCharlottesville, Virginia
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
